Keryx Biopharmaceuticals vs. AEterna Zentaris - Seeking Alpha PDF Print
Seeking Alpha
KERX's goal is to try to commercialize new pharmaceutical products that focus on serious conditions like renal disease and cancer. The company for 2011 will not expect to recognize revenue based on sales of its products, but has recorded license

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.